Jennifer L Beaumont

13PUBLICATIONS
44CO-AUTHORS
Pharmaceutical delivery technologiesPredictive and prognostic markersRheumatology and arthritisPsychosocial aspects of childbirth and perinatal mental healthEducational counselling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 30, 2024
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials.

April W Armstrong, Matthias Augustin, Jennifer L Beaumont

|Jan 12, 2024
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab.

Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes

|May 01, 2023
Integrating PROMIS Measures in a Treat-to-Target Approach to Standardize Patient-Centered Treatment of Rheumatoid Arthritis.

George J Greene, Jennifer L Beaumont, Emily J Bacalao

|May 31, 2021
Targeted eHealth Intervention to Reduce Breast Cancer Survivors' Fear of Recurrence: Results From the FoRtitude Randomized Trial.

Lynne I Wagner, Janet A Tooze, Daniel L Hall

|Mar 16, 2021
Meaningful Change Thresholds for Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue and Pain Interference Scores in Patients With Rheumatoid Arthritis.

Jennifer L Beaumont, Elizabeth S Davis, Jeffrey R Curtis

|Nov 27, 2020
Your Path to Transplant: A randomized controlled trial of a tailored expert system intervention to increase knowledge, attitudes, and pursuit of kidney transplant.

Amy D Waterman, John D Peipert, Yujie Cui

Pageof 3

Frequent Collaborators

3 joint publications

Amy Waterman

2 joint publications

Subhashis Banerjee

2 joint publications

Stacie Hudgens

2 joint publications

Tan P Pham